Connect your AI

Utah Medical Products UTMD Total Equity

Total Equity at other companies

Becton, Dickinson and CompanyBDX

$24.13B-4.4%

TFX

TeleflexTFX

$3.08B-24.7%

The Cooper Companies, Inc.COO

$8.24B-0.6%

IAR

Integra LifeSciencesIART

$1.04B-31.6%

Merit Medical SystemsMMSI

$1.63B+13.9%

PDE

Pro-Dex, Inc.PDEX

$45.2M+28.1%

Other financials

Income statement

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total assets$124.4M+1.5%

Cash flow

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Utah Medical Products's total equity?: Utah Medical Products (UTMD) reported total equity of $120.37M in Q1 2026.
How has Utah Medical Products's total equity changed year-over-year?: Utah Medical Products's total equity increased by 2.8% year-over-year, from $117.05M to $120.37M.
What is the long-term trend for Utah Medical Products's total equity?: Over 5 years (2020 to 2025), Utah Medical Products's total equity has grown at a 3.0% compound annual growth rate (CAGR), from $102.82M to $119.27M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.